QualityDipStocks / Finance · Property-Casualty Insurers
SiriusPoint SPNT
Outside our quality screen, so we don’t track its dips. It’s 1% below its 52-week high.
Outside our quality screen, 6% over its Market Value. No fair value estimate for now: our model doesn’t fit it reliably.
Worth knowing
- Share count down 28% in 2 years
From the data on this page, as of the last close. How we pick these
- Fair value est.
- n/a
- Market Value
- $24.64price +6%
- Off 52-wk high
- −1%
- Risk vs market
- Lowbeta 0.02
5 bullish · 4 bearish See why
Repriced or dip?
Near its high
The price is 1% below its 52-week high (Jul 28), but the business held up: shares outstanding fewer shares, each owns more, earnings per share +7.6%, revenue growth rate −0.4 pts.
Some numbers held up (shares outstanding fewer shares, each owns more, earnings per share +7.6%, revenue growth rate −0.4 pts), others slipped. The price is 1% below its 52-week high.
The price is 1% below its 52-week high, and the business changed too.
Within 10% of its 52-week high, so there is no dip to judge yet.
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 6.6×; 52-wk low: P/E 11.7×; now: P/E 6.1×.
| High | Low | Now | |
|---|---|---|---|
| Price | $26.31Jul 28 | $18.20Oct 31 | $26.01 |
| P/E | 6.6× | 11.7× | 6.1× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Banks, insurers and lenders: cash flow includes deposits and loans, so a cash-flow model doesn't fit; we show P/E at each point instead. P/E = that day's close × diluted shares / 12-month net income, using only the filings that were public on that day.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
Estimate unreliable for SPNT: earnings swing too much for a book-value model (return on equity ranged from -17% to 23% across FY2021–2025 and the latest 12 months). We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much SPNT moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Has moved mostly independently of the market, but its own price swings are 2.1× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.02
- Volatility
- 27% vs 13% SPY
- Correlation SPY
- 0.01
- Correlation QQQ
- −0.12
Valuation details
MV $24.64
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
GrowthDiluted EPS grew 250% to $3.64 in FY2025.
ValuationP/E of 6.1× vs a 13.6× median for the 291 Finance companies we cover.
GrowthSales grew 23% to $3.2B over the last 12 months vs the 12 months before (SEC filings).
GrowthSales compounded 15% a year from FY2022 to FY2025.
ProfitabilityReturn on equity of 23% over the last 12 months, up 5 points in two years.
Top bearish points 4 of 5
Cash returnsShare count up 0.3% over 12 months, above the −1.7% median for the 249 Finance companies we cover.
ProfitabilityNet margin of 15%, below the 22% median for the 281 Finance companies we cover.
QualityDoesn’t pass our quality screen: sales down vs the year-ago quarter.
ValuationTrades 5.5% above its Market Value of $24.64, the average price paid since the Jul 29 filing.
All fundamentals
P/E 6.1 · ROE 23% · Sales +23%
Valuation
- P/E
- 6.1×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for an insurer
- FCF yield
- n/acash flow isn't a clean measure for an insurer
- EV / EBITDA
- n/anot meaningful for an insurer
- Price / sales
- 0.92×
- Price / book
- 1.32×
- Market cap
- $3.0Blisted
- Enterprise value
- $3.1B
Growth
- Revenue, 12 months
- $3.2B
- Sales growth, 12 months
- +22.6%vs the 12 months before
- Sales growth, 3 yrs
- +15.0%/yrfrom FY2022
- Diluted EPS, 12 months
- $4.06
- EPS growth, last FY
- +250.0%
- Net income, 12 months
- $495M
- Net income growth
- +368%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for an insurer
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 15.2%
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 23%
- Return on invested capital
- n/anot meaningful for an insurer
Balance sheet
- Cash & short-term inv.
- $615M
- Total debt
- $676M
- Net cash
- n/anot meaningful for an insurer
- Debt / equity
- n/adeposits/float make debt/equity not comparable for an insurer
- Interest coverage
- n/anot meaningful for an insurer
Cash flow & returns
- Free cash flow, 12 months
- n/anot reported in its SEC filings
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 0%
- Payout ratio
- 0%
- Buybacks, 12 months
- $73M2.4% of market cap
- Share count, 1 year
- +0.3%diluted shares vs a year ago
- Stock-based comp
- $40M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From SiriusPoint’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.2B · Sales 0%
- Free cash flow, 12 months$0.2B
- Free-cash-flow yield6.7%
- Return on equity23%
- Sales growth (latest quarter vs year-ago quarter)0%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $26.01
- 52-wk lowlowest close, 1 year$18.20−30.0%
- Market Valueavg paid since Jul 29$24.64−5.3%
- PriceMon Nov 2 close$26.01you are here
- 52-wk highhighest close, 1 year$26.31+1.2%
Momentum & 52-week range
RSI 62 · 5 days +0.9%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 5
- DateThu Nov 5, after the close
- Consensus EPS$0.61
- Year-ago EPS$0.72
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
SPNT is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on SiriusPoint in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Property-Casualty Insurers
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.